LRRK2 and nonpapillary renal cell carcinoma: We also examined the mutation rates in ccRCC in the cBioPortal database for the eight genes from which PCDI was constructed and found a higher mutation rate of 15% for LRRK2 and a lower mutation rate of 4% for PYCARD compared to the other six genes from which PCDI was constructed (Figure S2).